Compare GDHG & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GDHG | CCEL |
|---|---|---|
| Founded | 2008 | 1989 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Managed Health Care |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.9M | 29.6M |
| IPO Year | 2022 | 2022 |
| Metric | GDHG | CCEL |
|---|---|---|
| Price | $1.71 | $3.46 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.8K | ★ 8.9K |
| Earning Date | 07-11-2025 | 04-14-2026 |
| Dividend Yield | N/A | ★ 4.32% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $25,384,279.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $341.00 |
| Revenue Growth | N/A | ★ 9.76 |
| 52 Week Low | $0.16 | $2.72 |
| 52 Week High | $8.69 | $5.56 |
| Indicator | GDHG | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 40.22 | 50.36 |
| Support Level | $1.59 | $3.18 |
| Resistance Level | $1.97 | $4.24 |
| Average True Range (ATR) | 0.11 | 0.35 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 23.26 | 26.09 |
Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, it manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants. it opearts in the Cayman Islands, PRC, BVI, and HK.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.